The Procter & Gamble Manufacturing Company
FDA inspection history in Greensboro, North Carolina, 2017 to 2023
- 2
- Form 483s
Every document, by year
- Form 483
2017: one Form 483; 2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2017One Form 483, at Greensboro, North Carolina.
- 2017The longest 483 on file: 4 observations over 6 pages at Greensboro, North Carolina.
- 2023One Form 483, at Greensboro, North Carolina.
Cited most
Across all The Procter & Gamble Manufacturing observations on file
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures2
- 21 CFR 211.100(b)Written procedures; deviations1
- 21 CFR 211.110(a)Sampling and testing of in-process materials and drug products1
- 21 CFR 211.198(a)Complaint files1
- 21 CFR 211.67(a)Equipment cleaning and maintenance1
The complete The Procter & Gamble Manufacturing file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Greensboro, North Carolina
Two Form 483s · 2017 to 2023 · 6 observations
Latest: Form 483, Mar 10, 2023 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-03-10 | 483 Form 483 | Greensboro, North Carolina | 2 | $99 |
| 2017-11-17 | 483 Form 483 | Greensboro, North Carolina | 4 | $99 |
Investigators on these documents
FEI number 1017175 · most recent document Mar 10, 2023
About The Procter & Gamble Manufacturing Company
How many FDA Form 483s has The Procter & Gamble Manufacturing Company received?
FDA Intel has 2 Form 483s on file for The Procter & Gamble Manufacturing Company; the most recent is dated Mar 10, 2023.
When was The Procter & Gamble Manufacturing Company last inspected by FDA?
The most recent FDA inspection document on file for The Procter & Gamble Manufacturing Company is a Form 483 dated Mar 10, 2023, for the site in Greensboro, North Carolina.
What did FDA cite at The Procter & Gamble Manufacturing Company?
The regulations cited most in the observations on file for The Procter & Gamble Manufacturing Company are 21 CFR 211.84 (Testing and approval or rejection of components, drug product containers, and closures), 2 times; 21 CFR 211.100(b) (Written procedures; deviations), 1 time; 21 CFR 211.110(a) (Sampling and testing of in-process materials and drug products), 1 time.